| [January 29, 2016] |
 |
Metastatic Pancreatic Cancer - Pipeline Review - Key Players & Comparative Analysis - Research and Markets
Research and Markets (http://www.researchandmarkets.com/research/hd6r42/metastatic)
has announced the addition of the "Metastatic
Pancreatic Cancer - Pipeline Review, H2 2015" report to their
offering.
This report provides comprehensive information on the therapeutic
development for Metastatic Pancreatic Cancer, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Metastatic Pancreatic Cancer and special features on late-stage and
discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introductin
-
Metastatic Pancreatic Cancer Overview
-
Therapeutics Development
-
Pipeline Products for Metastatic Pancreatic Cancer - Overview
-
Pipeline Products for Metastatic Pancreatic Cancer - Comparative
Analysis
-
Metastatic Pancreatic Cancer - Therapeutics under Development by
Companies
-
Metastatic Pancreatic Cancer - Therapeutics under Investigation by
Universities/Institutes
-
Metastatic Pancreatic Cancer - Pipeline Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Metastatic Pancreatic Cancer - Products under Development by Companies
-
Metastatic Pancreatic Cancer - Products under Investigation by
Universities/Institutes
-
Metastatic Pancreatic Cancer - Companies Involved in Therapeutics
Development
Companies Mentioned:
-
AbbVie Inc.
-
Aduro BioTech, Inc.
-
ArQule, Inc.
-
Array BioPharma Inc.
-
AstraZeneca Plc
-
AVEO Pharmaceuticals, Inc.
-
Axcentua Pharmaceuticals AB
-
Biothera, Inc.
-
Boehringer Ingelheim GmbH
-
Boston Biomedical, Inc.
-
Bristol-Myers Squibb Company
-
Cantex Pharmaceuticals, Inc.
-
Celgene Corporation
-
Clovis Oncology, Inc.
-
Cornerstone Pharmaceuticals, Inc.
-
CTI (News - Alert) BioPharma Corp.
-
CytRx Corporation
-
Eleison Pharmaceuticals, Inc.
-
Eli Lilly and Company
-
Ensol Biosciences Inc.
-
Erytech Pharma SA
-
F. Hoffmann-La Roche Ltd.
-
Fountain Biopharma Inc.
-
Gilead Sciences, Inc.
-
GlaxoSmithKline Plc
-
(30+ Others)
For more information visit http://www.researchandmarkets.com/research/hd6r42/metastatic
View source version on businesswire.com: http://www.businesswire.com/news/home/20160129005413/en/
[ Back To TMCnet.com's Homepage ]
|
